Antibiotic-Resistant Infections Among Inpatients with Coronavirus Disease 2019 (COVID-19) in US Hospitals-Reference-Cited by-同舟云学术

Antibiotic-Resistant Infections Among Inpatients with Coronavirus Disease 2019 (COVID-19) in US Hospitals

Published:2022-07-02 Issue:Supplement_2 Volume:75 Page:S294-S297
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Baggs James¹,Rose Ashley N¹,McCarthy Natalie L¹,Wolford Hannah¹,Srinivasan Arjun¹,Jernigan John A¹,Reddy Sujan C¹

Affiliation:

1. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention , Atlanta, Georgia , USA

Abstract

Abstract We described bacterial/fungal coinfections and antibiotic-resistant infections among inpatients with a diagnosis of coronavirus disease 2019 (COVID-19) and compared findings in those with a diagnosis of influenza like illness. Less than 10% of inpatients with COVID-19 had bacterial/fungal coinfection. Longer lengths of stay, critical care stay, and mechanical ventilation contribute to increased incidence of hospital-onset infections among inpatients with COVID-19.

Funder

US Centers for Disease Control and Prevention

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac517/44383003/ciac517.pdf

Reference13 articles.

1. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis;Langford;Clin Microbiol Infect,2020

2. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge;Nori;Infect Control Hospital Epidemiol,2021

3. Trends in antibiotic use in United States Hospitals during the coronavirus disease 2019 pandemic;Rose;Open Forum Infect Dis,2021